Screening Potential Drugs for COVID-19 Based on Bound Nuclear Norm Regularization

Screening Potential Drugs for COVID-19 Based on Bound Nuclear Norm Regularization

The novel coronavirus pneumonia COVID-19 infected by SARS-CoV-2 has attracted worldwide attention. It is urgent to find effective therapeutic strategies for stopping COVID-19. In this study, a Bounded Nuclear Norm Regularization (BNNR) method is developed to predict anti-SARS-CoV-2 drug candidates....

Full description

Bibliographic Details
Main Authors: Juanjuan Wang, Chang Wang, Ling Shen, Liqian Zhou, Lihong Peng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Genetics
Subjects:
SARS-CoV-2
bounded nuclear norm regularization
virus-drug association
FDA-approved drugs
molecular docking
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2021.749256/full

Internet

https://www.frontiersin.org/articles/10.3389/fgene.2021.749256/full

Similar Items